These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Enhanced CRISPR-Cas9 RNA system delivery using cell penetrating peptides-based nanoparticles for efficient in vitro and in vivo applications. Guzman Gonzalez V; Grunenberger A; Nicoud O; Czuba E; Vollaire J; Josserand V; Le Guével X; Desai N; Coll JL; Divita G; Faure V J Control Release; 2024 Dec; 376():1160-1175. PubMed ID: 39521064 [TBL] [Abstract][Full Text] [Related]
10. Unlocking Fungal Potential: The CRISPR-Cas System as a Strategy for Secondary Metabolite Discovery. Leal K; Rojas E; Madariaga D; Contreras MJ; Nuñez-Montero K; Barrientos L; Goméz-Espinoza O; Iturrieta-González I J Fungi (Basel); 2024 Oct; 10(11):. PubMed ID: 39590667 [TBL] [Abstract][Full Text] [Related]
11. Trends in Surgical and Nonsurgical Aesthetic Procedures: A 14-Year Analysis of the International Society of Aesthetic Plastic Surgery-ISAPS. Triana L; Palacios Huatuco RM; Campilgio G; Liscano E Aesthetic Plast Surg; 2024 Oct; 48(20):4217-4227. PubMed ID: 39103642 [TBL] [Abstract][Full Text] [Related]
12. Unlocking data: Decision-maker perspectives on cross-sectoral data sharing and linkage as part of a whole-systems approach to public health policy and practice. Tweed E; Cimova K; Craig P; Allik M; Brown D; Campbell M; Henderson D; Mayor C; Meier P; Watson N Public Health Res (Southampt); 2024 Nov; ():1-30. PubMed ID: 39582242 [TBL] [Abstract][Full Text] [Related]
15. Integrating CRISPR technology with exosomes: Revolutionizing gene delivery systems. Dara M; Dianatpour M; Azarpira N; Tanideh N; Tanideh R Biochem Biophys Res Commun; 2024 Dec; 740():151002. PubMed ID: 39566123 [TBL] [Abstract][Full Text] [Related]
16. CRISPR Technology Acts as a Dual-Purpose Tool in Pig Breeding: Enhancing Both Agricultural Productivity and Biomedical Applications. Fu B; Ma H; Huo X; Zhu Y; Liu D Biomolecules; 2024 Nov; 14(11):. PubMed ID: 39595585 [TBL] [Abstract][Full Text] [Related]
17. Australia in 2030: what is our path to health for all? Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362 [TBL] [Abstract][Full Text] [Related]
18. Chahine ZM; Gupta M; Lenz T; Hollin T; Abel S; Banks C; Saraf A; Prudhomme J; Bhanvadia S; Florens LA; Le Roch KG Elife; 2024 Dec; 12():. PubMed ID: 39636094 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]